China-based Lifetech Scientific Corporation (HKG: 1302) has announced a partnership agreement with compatriot firm Jenscare Scientific Co., Ltd. This strategic collaboration aims to enhance the development and marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders.
Partnership Details
Jenscare, based in Ningbo, is focused on structural heart disease intervention devices, while Lifetech is engaged in the manufacturing and marketing of minimally invasive interventional medical devices. The two companies will work together on business development at home and abroad, project investment and financing, and more. Specifically, Lifetech will assist Jenscare in performing clinical studies and regulatory filings, and will cooperate with Jenscare on product marketing and sales in the Chinese mainland, Asia-Pacific, Europe, North America, and Latin America.
Global Expansion and Market Reach
This partnership is expected to significantly expand the market reach of both companies, leveraging Lifetech’s expertise in manufacturing and marketing and Jenscare’s focus on structural heart disease intervention devices. The collaboration aims to enhance the availability of innovative medical devices globally, particularly in key regions such as the Chinese mainland, Asia-Pacific, Europe, North America, and Latin America.
No Financial Details Disclosed
No financial details of the partnership were disclosed, indicating a focus on strategic alignment and long-term growth rather than immediate financial gains. This collaboration is expected to drive innovation and market expansion in the field of minimally invasive interventional medical devices.-Fineline Info & Tech
